FORTREA HOLDINGS INC. (FTRE) ROE
- 2026-06-30: ROE -16.25%.
- 2026-03-31: ROE -84.98%.
- 2025-12-31: ROE -175.01%.
- 2025-09-30: ROE -174.74%.
Complete source-backed roe history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -16.25% |
| 2026-03-31 | -84.98% |
| 2025-12-31 | -175.01% |
| 2025-09-30 | -174.74% |
| 2025-06-30 | -174.29% |
| 2025-03-31 | -92.04% |
| 2024-12-31 | -24.11% |
| 2024-09-30 | -21.26% |
| 2024-06-30 | -21.07% |
| 2024-03-31 | -8.71% |
| 2023-12-31 | -1.47% |
| 2023-09-30 | 3.31% |
| 2023-06-30 | 7.47% |
| 2023-03-31 | 4.88% |
| 2022-12-31 | 5.57% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -175.01% |
| 2024-12-31 | -24.11% |
| 2023-12-31 | -1.47% |
| 2022-12-31 | 5.57% |
| 2021-12-31 | 3.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |